Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.

PloS one - 1 Jan 2011

Kim Saorin, Nguon Chea, Guillard Bertrand, Duong Socheat, Chy Sophy, Sum Sarorn, Nhem Sina, Bouchier Christiane, Tichit Magali, Christophel Eva, Taylor Walter R J, Baird John Kevin, Menard Didier

Abstract excerpt

Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareStart™ G6PD deficiency screening test (Access Bio, New Jersey, USA) by comparing its performance to quantitative G6PD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Cambodia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Geography

Share to Glucosephosphate Dehydrogenase

Share to Glucosephosphate Dehydrogenase Deficiency

Share to Reagent Kits, Diagnostic

Share to Spectrophotometry

Share to Temperature

Source

Open in PubMed Open full text

Identifiers

PMID: 22164279
DOI: 10.1371/journal.pone.0028357
PMCID: PMC3229584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.PMID 22164279Read ↗

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.Semantic proximity Read ↗

Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.Semantic proximity Read ↗

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity Read ↗

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, BangladeshSemantic proximity Read ↗

Clinical Performance of the STANDARD™ G6PD Test in IndiaSemantic proximity Read ↗

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.Semantic proximity Read ↗

Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.Semantic proximity Read ↗

Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiencySemantic proximity Read ↗

G6PD deficiency in malaria endemic areas of Nepal.Semantic proximity Read ↗

Development and implementation of droplet digital PCR assays for accurate quantification of Plasmodium vivax parasitemia and G6PD viangchan genotyping.Semantic proximity Read ↗

Diagnostic accuracy of the Point-of-Care Standard G6PD test™ (SD Biosensor) for Glucose-6-phosphate dehydrogenase deficiency: a systematic review of the literatureSemantic proximity Read ↗

Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in ThailandSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.